Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Perspectives on Wearable Device Data

Posted by Matt Breese on Dec 27, 2017

In 2018, we will see a rising amount of health-related data generated from personal devices such as smartphones and wearables. One potential application for these tools is to monitor patients in clinical trials remotely.
 
Historically, some concerns with wearable device-derived data have been the lack of regulatory guidance and the difficulty of ensuring data quality.
 
Read More

Topics: Data & Analytics

Trends That Matter for BCBS Plans

Posted by Matt Breese on Dec 21, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from influencers to highlight general trends affecting the pharmaceutical and healthcare industries. This week's featured topic is Blue Cross and Blue Shield Plans.

With their limited geographic footprint, strong name recognition and broad provider networks, Blue Cross and Blue Shield plans face both challenges and opportunities in market positioning. 

Read More

Topics: Industry Trends

MMIT Reality Check on Hemophilia (Dec 2017)

Posted by Matt Breese on Dec 20, 2017

According to our recent payer coverage analysis for hemophilia treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing

Perspectives on Kidney Cancer

Posted by Matt Breese on Dec 19, 2017

There has been an increasing prevalence of kidney cancer during the past decade. Several pharma manufacturers are stepping up to the plate with promising treatment options. Through 2024, the global market for kidney cancer drugs is expected to continue to grow. 
 
According to an analysis conducted by Grand View Research"The Asia-Pacific market is estimated to witness the fastest growth rate for the kidney cancer drugs market."
 
Read More

Topics: Specialty, Market Access

Trends That Matter for Viscosupplements

Posted by Matt Breese on Dec 14, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is viscosupplements,. 

According to our recent payer coverage analysis for viscosupplements, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

Read More

Topics: Specialty, Industry Trends

Perspectives on Marketing to Millennials

Posted by Matt Breese on Dec 12, 2017

Many younger millennials have never had their own health insurance coverage and don’t understand how health insurance works. Carriers must explain how their plans work and emphasize values beyond medical services to get millennials to enroll in health plans and stay enrolled.
 
For example, nutrition programs such as BlueShield's HealthyLife Rewards emphasize and reward their subscribers for healthy eating habits. 
 
Read More

Topics: Payer, Branding & Marketing

Trends That Matter for Multiple Sclerosis

Posted by Matt Breese on Dec 7, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is multiple sclerosis treatments. 

According to our recent payer coverage analysis for multiple sclerosis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

Read More

Topics: Specialty, Industry Trends

Perspectives on the Anti-Epilepsy Pipeline

Posted by Matt Breese on Dec 5, 2017

As 2018 approaches, the anti-epilepsy market is getting more attention in the pharma scene. The significant drivers of growth in this area are the development of third generation drugs, increased screening of patients, and improved access to anti-epilepsy treatments. 
 
Significant market constraints include the high cost of clinical trials and the need for high-level post market surveillance.
 
Read More

Topics: Specialty, Market Access

MMIT Reality Check on Multiple Sclerosis (Nov 2017)

Posted by Matt Breese on Nov 30, 2017

According to our recent payer coverage analysis for multiple sclerosis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape.

To help make sense of this new research, MMIT's team of experts analyzes the data and summarizes the key findings for you. The following are brief highlights. To read the full piece, including payer coverage, drug competition and prescriber trends, click here.

Read More

Topics: Specialty, Market Access, Payer, Branding & Marketing

Trends That Matter for G-CSF Treatments

Posted by Matt Breese on Nov 30, 2017

 

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is granulocyte-colony stimulating factor (G-CSF) treatments. 

According to MMIT's recent payer coverage analysis for G-CSF treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. Here’s a look at more recent trends.

Read More

Topics: Industry Trends, Market Access, Payer